Probiotics for the prevention of antibiotic-associated diarrhoea: a systematic review and meta-analysis
The Employer Coverage Debate The big topic of conversation for plan sponsors in this arena centers around covering injectable GLP-1 drugs for weight loss and how to manage the associated costs
As the Mayo Clinic notes, GLP-1s are redefining how we treat obesity , but they are not magic pills, they must be part of a larger medical plan (Mayo Clinic)
Legal Landscape and Research Use Only Status A PI reviewing a purchase request for a KLOW blend usually faces a practical problem before any experiment begins
territories) to certain people with Medicare drug coverage (Part D) , including: A standalone Medicare drug plan (PDP) A Medicare Advantage (MA) coordinated care plan with drug coverage (including HMO, HMOPOS, and Local and Regional PPO plans) (MA-PD) A Special Needs Plan (SNP) An Employer/union group waiver plan (EGWP) The Limited Income Newly Eligible Transition (LI NET) program Who's eligible You must be 18 or older and meet one of these requirements when you start GLP-1 therapy: You have a body mass index (BMI) of 35 or higher
Journal of the American College of Nutrition, 36 (8), 631639
